Rocket Lab’s Record Run Hits a Speed Bump as $90M Space Force Deal Opens New Orbit

Rocket Lab’s blistering 12-month rally — which has lifted the stock more than 418% — stumbled on Friday, with shares sliding roughly 4% to close at $141.87. The retreat from the 52-week high of $150.23, set just two days earlier, came amid a broader sector chill rather than company-specific trouble. SpaceX trimmed its IPO valuation target from over $2 trillion to at least $1.8 trillion, and Blue Origin suffered a failed rocket test, reminding investors of the technical perils baked into the space industry.

Yet beneath the surface volatility, Rocket Lab is quietly reshaping its business model. The company secured a $90 million contract with the U.S. Space Force’s Space Systems Command to build and operate two geostationary satellites — its first venture into the GEO market. Taking on the role of prime contractor, Rocket Lab will handle design, manufacturing, integration, and up to five years of on-orbit operations. The satellites will use the in-house Lightning bus, adapted for the harsh radiation and thermal environment of geostationary orbit, and carry the Heimdall optical payload, a technology inherited from the GEOST acquisition in 2025.

The GEO contract is more than a single order; it signals a strategic pivot from pure launch provider to full-spectrum mission supplier for government clients. That ambition runs parallel to the completed acquisition of Motiv Space Systems, a robotics and precision-mechanisms specialist whose capabilities will support complex satellite builds. Together, these moves push Rocket Lab closer to the established defense and aerospace primes.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Operational momentum is also building on another front. Rocket Lab passed the System Requirements Review for an $816 million contract with the Space Development Agency, part of the “Tracking Layer Tranche 3” program to build 18 satellites on the Lightning platform. That SDA backlog alone exceeds $1.3 billion. The company’s total order book now stands at roughly $2.2 billion, and cash reserves are a healthy $1.48 billion. Revenue jumped 63.4% in the latest quarter to $200.35 million, keeping the growth narrative intact.

The Friday selloff trimmed Rocket Lab’s market capitalization from about $85.7 billion to $77.8 billion — a level that still carries a hefty premium. Wall Street’s average price target sits at $97.19, roughly 30% below the current price. Stifel rates the stock a Buy with a $105 target, while Cantor Fitzgerald is Overweight at $96. The consensus is a “Moderate Buy,” but the valuation gap is wide.

Insider sales added a note of caution. CFO Adam Spice sold roughly 62,700 shares at an average of $142.57, netting about $9 million. Senior Vice President Arjun Kampani offloaded 70,000 shares, and executive Marvin Bradford Clevenger sold around 15,500. All transactions were executed through pre-arranged 10b5-1 trading plans to cover tax liabilities from equity compensation. Spice still holds nearly 1 million shares directly — hardly a vote of no confidence.

Friday’s pullback looks less like a warning and more like a technical consolidation after an extraordinary run. Whether the stock can hold these levels will likely depend on the next quarterly report and whether Rocket Lab keeps hitting its SDA milestones on schedule. The new GEO contract adds a high-stakes test: if executed smoothly, it could unlock a fresh stream of government orders in a market where reliability trumps cost.

Ad

Rocket Lab USA Stock: New Analysis - 30 May

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | ROCKET | boerse | 69446274 |